HUNTER CAPITAL AB

Hunter Capital AB Stock

Stocks

HUNTER

SE0022087649

End-of-day quote NORDIC GROWTH MARKET 29/09/2026			5-day change	1st Jan Change
10.35 ^SEK	-7.17%		-.--%	-26.07%

09-17	Hunter Capital buys shares in C100 for $0.5m (R)	FW
09-10	C100 returns to its regular place on Spotlight	FW

Valuation: Hunter Capital AB

Market Cap	46.99M 4.74M 4.25M 3.93M 3.56M 6.65M 451M 6.73M 18.72M 236M 17.78M 17.41M 750M	P/E 2024	2.2x	P/E 2025	1.92x
Enterprise Value	45.81M 4.62M 4.14M 3.83M 3.47M 6.48M 440M 6.56M 18.24M 230M 17.33M 16.97M 731M	EV / Sales 2024	11.4x	EV / Sales 2025	41.1x
Free-Float	-	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Chart: Hunter Capital AB

NORDIC GROWTH MARKETSEK

Markets		Quality
NORDIC GROWTH MARKET	HUNTER	End-of-day quote
Deutsche Boerse AG	2DD0	Delayed

Latest news: Hunter Capital AB

09-17	Hunter Capital buys shares in C100 for $0.5m (R)	FW
09-10	C100 returns to its regular place on Spotlight	FW
09-10	Hunter Capital cuts its stake in C100, falls below 90%	FW
09-08	Hunter Capital reaches over 90 percent in C100 after mandatory cash offer	FW
09-07	Hunter Capital reaches over 90 percent of the shares in C100	FW
08-28	Hunter Capital AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-28	Hunter Capital posted a lower profit in the second quarter	FW
08-24	C100's board advises against Hunter Capital's offer	FW
07-31	Hunter Capital raises its offer for C100 after correction	FW
07-29	Hunter Capital submits mandatory offer for C100 (update)	FW
07-29	Hunter Capital makes a mandatory offer for C100	FW
07-15	Hunter Capital cuts stake in C100 ahead of mandatory takeover offer	FW
07-07	Hunter Capital sells shares in C100 for just over 3 million kronor	FW

Press Releases: Hunter Capital AB

07-06	Hunter Capital RTO 1 : Hunter Capital RTO 1 AB (publ) provides an update on the planned transaction with ResoTher Pharma A/S	PU
03-30	Hunter Capital RTO 1 : Hunter Capital RTO 1 signs Letter of Intent for reverse takeover of Nordic Phase 2 biotech company at an implied valuation of SEK 365–405 million	PU
05/09/25	Hunter Capital: Hunter Capital AB (publ) acquires warrants and shares in SynAct Pharma AB (publ) from Heights Capital Management	PU

More press releases

Quotes and Performance

1 day	-7.17%
1 month	-2.36%
3 months	-6.76%
6 months	+3.71%
Current year	-26.07%

Price Extremes

1 month	10.35		10.35
Current year	7.98		17.6
1 year	7.98		34.4
3 years	2		34.4
5 years	2		214.5
10 years	2		940

Managers and Directors: Hunter Capital AB

Manager	Title	Age	Since
Jacob Alexander Eriksson CEO	Chief Executive Officer	34	02/09/2024

Director	Title	Age	Since
David Olhed BRD	Director/Board Member	42	21/05/2021
Oliver Alexander Aleksov CHM	Chairman	32	01/01/2023
Jacob Alexander Eriksson BRD	Director/Board Member	34	01/01/2023

Financials

	2024	2025
Net sales	1.04M 105K 94.46K 87.33K 79.09K 148K 10.03M 150K 416K 5.25M 395K 387K 16.66M	1.52M 153K 137K 127K 115K 215K 14.58M 217K 605K 7.63M 574K 562K 24.22M
Net income	8.25M 832K 747K 690K 625K 1.17M 79.26M 1.18M 3.29M 41.48M 3.12M 3.06M 132M	33.13M 3.34M 3M 2.77M 2.51M 4.69M 318M 4.74M 13.19M 166M 12.53M 12.27M 528M
Net Debt	-6.21M -626K -562K -519K -470K -879K -59.63M -889K -2.47M -31.21M -2.35M -2.3M -99.07M	-1.19M -120K -108K -99.44K -90.06K -168K -11.42M -170K -474K -5.97M -450K -440K -18.97M

Projected Income Statement - Annual - Hunter Capital AB

* Estimated data More financial data

Company Profile

Employees

1

Sector

-

More about the company

Stock Market
Stocks
HUNTER Stock

The best tools reserved for subscribers to boost the performance of your investments!